6 crore, according to NSE data. The shares changed hands at Rs 1,695 apiece.
90 lakh shares in two transactions. The trust sold 12,21,820 shares in one transaction and 1,68,180 shares in another, with both deals executed at Rs 1,695 per share.
The transaction comes as Entero Healthcare shares have gained sharply in recent sessions. 60.
80. 50 crore on the NSE..
Should investors chase the rally or stay cautious? Prasid Uno Family Trust holdingThe block deal is notable given the trust's earlier stake in the company.
45% of Entero Healthcare Solutions, as of June 30, 2026, according to BSE shareholding data. 19% of the company's equity, based on the June 30 shareholding base.
The latest transaction data does not specify the trust's post-deal holding. Entero Healthcare shares touched a 52-week high of Rs 1,920 on September 8 on the NSE.
The stock's 52-week low stands at Rs 944, recorded on December 29, 2025. About Entero Healthcare SolutionsIncorporated in 2018, Entero Healthcare Solutions is a healthcare products distributor in India.
Its technology-driven platform provides distribution services to pharmacies, hospitals and clinics across the country. The company connects healthcare-product manufacturers with healthcare providers through its integrated distribution network, while enabling pharmacies, hospitals and clinics to access a broad range of healthcare products.
The company's distribution platform is designed to provide healthcare-product manufacturers with wider reach and accessibility, while its network enables healthcare providers to source products through its relationships with manufacturers and distribution infrastructure. Disclosure: This article has been written by Kumar Gaurav, who is not a SEBI-registered Research Analyst or an investment advisor.
Gaurav does not hold any financial interest in the company as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution.
They should not be construed as the views or recommendations of the EconomicTimes Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment.
